Ovintiv Inc. (OVV) Balance Sheet
As of 2026-06-30 (10-Q), Ovintiv Inc. (OVV) reported total assets of $19.3B, total liabilities of $7.8B and shareholders' equity of $11.5B, according to EquiReason's reading of its SEC filings. Cash and equivalents: $700.0M. Long-term debt: $3.7B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OVVOvintiv Inc.Follow OVV — free
—
Price chart with a free account
- Market cap
- 19.9B
- P/E TTM
- —
- Dividend yield
- 1.7%
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2018 Jan 19 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.06 | 0.19 | 0.01 | 0.20 | 0.01 | 0.00 | 0.04 | 0.04 | 0.70 | |
| Short-term investments | — | — | — | — | — | — | — | 0.25 | 0.00 | |
| Current assets | 2.68 | 1.87 | 1.25 | 1.59 | 1.70 | 1.68 | 1.37 | 1.52 | 2.25 | |
| Total assets | 15.20 | 21.49 | 14.47 | 14.06 | 15.06 | 19.99 | 19.25 | 20.39 | 19.28 | |
| Current liabilities | 2.07 | 2.43 | 2.42 | 2.75 | 2.78 | 2.81 | 2.68 | 2.80 | 2.23 | |
| Long-term debt | 3.70 | 6.97 | 6.37 | 4.79 | 3.18 | 5.45 | 4.85 | 4.39 | 3.70 | |
| Short-term debt | 0.50 | 0.00 | 0.52 | 0.00 | 0.39 | 0.28 | 0.60 | 0.81 | 0.00 | |
| Total liabilities | 7.68 | 11.56 | 10.63 | 8.98 | 7.37 | 9.62 | 8.92 | 9.20 | 7.78 | |
| Shareholders' equity | 7.52 | 9.93 | 3.84 | 5.07 | 7.69 | 10.37 | 10.33 | 11.20 | 11.50 |
USD billions · SEC XBRL
Ovintiv Inc. — questions
- How much cash does Ovintiv Inc. have?
- $700.0M in cash and cash equivalents as of 2026-06-30.
- How much debt does Ovintiv Inc. have?
- $3.7B of long-term debt and $0 due within a year as of 2026-06-30.
- What are Ovintiv Inc.'s total assets?
- $19.3B as of 2026-06-30.
- What is Ovintiv Inc.'s shareholders' equity?
- $11.5B as of 2026-06-30.
Every figure on this page comes from Ovintiv Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.